Comment on: Chauhan et al. (2010) Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians. Diabetes;59:2068-2074.
Gupta
Vipin
V
Ebrahim
Shah
S
D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000235:genetics*; D014644:Genetic Variation; D055106:Genome-Wide Association Study; D005843:Geography; D006801:Humans; D007194:India / Q000453:epidemiology; D018971:Insulin-Like Growth Factor Binding Protein 2 / Q000235:genetics; D047495:PPAR gamma / Q000235:genetics; D020641:Polymorphism, Single Nucleotide; D015203:Reproducibility of Results; D018570:Risk Assessment
D019941:Cyclin-Dependent Kinase Inhibitor p16; D018971:Insulin-Like Growth Factor Binding Protein 2; D047495:PPAR gamma